Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Benchmarking AAV-Cre mouse models for RNA-seq

ABSTRACT: Benchmarking AAV-Cre mouse models for RNA-seq

PROVIDER: PRJNA695279 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR13565634.fastq.gz	Fastqsanger.gz
	SRR13565635.fastq.gz	Fastqsanger.gz
	SRR13565636.fastq.gz	Fastqsanger.gz
	SRR13565637.fastq.gz	Fastqsanger.gz
	SRR13565638.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 28

Similar Datasets

Benchmarking AAV-Cre mouse models for RNA-seq

Project description:This study reports the baseline effects of systemic (i.v.) administration of AAV8-TBG-null and AAV8-TBG-Cre on the liver of male, wild-type C57Black6/J mice. We performed polyA RNAseq of whole liver lysates from mice 2, 4 and 7 days post AAV8-TBG-null or AAV8-TBG-Cre administration and compared their transcriptome with that of male mice of similar age that didn't receive any AAV8 (day 0). We report some changes in gene expression of genes related to circadian rythm and response to infection at certain timepoints. Our results demonstrate that AAV8-TBG vectors can have minimal effects on the murine liver transcriptome, something that needs to be considered and controlled when using this system for mouse experiments. Finally, we hope that this dataset will help other researchers to correctly interpret data obtained from mouse experimentation using AAV8-TBG vectors.

2021-06-01 | GSE165651 | GEO

Plasma DNA profile in DNASE1L3 deficiency-Mouse AAV samples

Project description:Plasma DNA profile in DNASE1L3 deficiency-Mouse AAV

| EGAS00001004409 | EGA

Benchmarking of modification-aware basecalling models

Project description:Benchmarking of modification-aware basecalling models

| PRJEB91026 | ENA

AAV-CYP46A1 gene therapy in mouse models of Huntington’s disease

Project description:AAV-CYP46A1 gene therapy in mouse models of Huntington’s disease

| PRJNA909255 | ENA

Molecular Mechanisms Limiting the Therapeutic Window of AAV Gene Therapy in Mouse Models of Blue Cone Monochromacy

Project description:Blue cone monochromacy (BCM) is an X-linked retinal disorder caused by mutations in the OPN1LW/OPN1MW gene locus, resulting in impaired cone function and structural degeneration. We conducted a comparative analysis of AAV-mediated gene therapy in Opn1lw/Opn1mw double knockout (DKO) and Opn1mwC198R/Opn1sw-/- (C198R) BCM mouse models and evaluated the therapeutic window, efficacy, and longevity. Our results demonstrate that the AAV8-Y733F capsid achieved superior cone rescue compared to AAV5. While both DKO and C198R models showed similar therapeutic windows and rescue longevity, treatment efficacy decreased markedly in older mutant mice. Structural analysis revealed that aged cones in both models displayed degenerative changes, including mislocalized mitochondria and compromised connecting cilia. At the molecular level, we observed reduced AAV-mediated transgene expression in DKO and C198R older cones, which may result from decreased transduction efficiency, decreased circular episome stability, genome-wide transcription/translation downregulation, targeted mRNA/protein degradation, or overall cone degeneration. Notably, the cone-specific promoters for Pde6c and Cngb3 maintained robust activity in degenerating cones. These findings suggest that combining an efficient AAV serotype with an optimized cone promoter could be a viable approach to extend the therapeutic window and enhance treatment longevity for BCM patients.

2025-03-11 | GSE289547 | GEO

Analysis of Protein Carrier AAV by LC-MS/MS

Project description:AAV is widely used for efficient delivery of DNA payloads. The extent to which the AAV capsid can be used to deliver a protein payload is unexplored. Here, we report engineered AAV capsids that directly package proteins – Protein Carrier AAV (pcAAV). Nanobodies inserted into the interior of the capsid mediate packaging of a cognate protein, including Green Fluorescent Protein (GFP), Streptococcus pyogenes Cas9, Cre recombinase, and the engineered peroxidase APEX2. We show that protein packaging efficiency is affected by the nanobody insertion position, the capsid protein isoform into which the nanobody is inserted, and the subcellular localization of the packaged protein during recombinant AAV capsid production; each of these factors can be rationally engineered to optimize protein packaging efficiency. We demonstrate that protein packaged within pcAAV retain their enzymatic activity and that pcAAV can bind and enter the cell to deliver the protein payload. Establishing pcAAV as a protein delivery platform expands the utility of AAV as a therapeutic and research tool.

2025-05-07 | PXD054767 | Pride

RiboTag and bulk RNA sequencing using AAV-Control and AAV-shLarp1 infected sensory neurons.

Project description:To investigate the role of the RNA-binding protein LARP1 and its interaction with ribosomal protein mRNAs in regenerating neurons, we performed total RNA and RiboTag sequencing analysis using AAV-Control or AAV-shLarp1 infected sensory neurons using RiboTag mice, RPL22HA+/+;Advillin-Cre+.

2025-09-01 | GSE301327 | GEO

RiboTag and bulk RNA sequencing using AAV-Control and AAV-shGpr151 infected sensory neurons.

Project description:To investigate the role of the Gpr151 mRNA and its interaction with ribosomal protein mRNA operon in regenerating neurons, we performed total RNA and RiboTag sequencing analysis using AAV-Control or AAV-shGpr151 infected sensory neurons using RiboTag mice, RPL22HA+/+;Advillin-Cre+.

2025-09-01 | GSE301324 | GEO

RiboTag and bulk RNA sequencing using AAV-shGpr151 and AAV-shGpr151 with AAV-e5'UTR infected sensory neurons.

Project description:After discovering that Gpr151 mRNA regulates the CSDE1-mediated rp-mRNA operon, we designed an engineered version of the 5'UTR of Gpr151 mRNA(e5'UTR), which has an enhanced interaction with CSDE1. To determine if this e5'UTR RNA can restore the down-regulated rp-mRNA operon formation in Gpr151 knockdowned neurons, we performed total RNA and RiboTag sequencing analysis using AAV-shGpr151 or AAV-shGpr151 with AAV-e5'UTR infected sensory neurons using RiboTag mice, RPL22HA+/+;Advillin-Cre+.

2025-09-01 | GSE301325 | GEO

RiboTag and bulk RNA sequencing using AAV-Control and AAV-shCsde1 infected sensory neurons.

Project description:Peripheral neurons can regenerate after nerve injury. To investigate the role of the RNA-binding protein CSDE1 and its interaction with ribosomal protein mRNAs in regenerating neurons, we performed total RNA and RiboTag sequencing analysis using AAV-Control or AAV-shCsde1 infected sensory neurons using RiboTag mice, RPL22HA+/+;Advillin-Cre+.

2025-09-01 | GSE301320 | GEO

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data